Mra(tocilizumab)    (DrugBank: Tocilizumab)

2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
46悪性関節リウマチ7
107若年性特発性関節炎3

46. 悪性関節リウマチ [臨床試験数:4,183,薬物数:2,538(DrugBank:401),標的遺伝子数:183,標的パスウェイ数:219
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
7 / 4,183 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00380601
(ClinicalTrials.gov)
May 200625/9/2006Phase?Open-label Study of MRA for Rheumatoid Arthritis(RA)An Open-label, Phase? Study to Evaluate the Efficacy and Safety of MRA in Patients With RARheumatoid ArthritisDrug: MRA(Tocilizumab)Chugai PharmaceuticalNULLCompleted20 YearsN/ABoth20Phase 3Japan
2NCT00144586
(ClinicalTrials.gov)
March 20052/9/2005Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JPAn Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Participated in Study MRA220JP or MRA221JPRheumatoid ArthritisDrug: MRA(Tocilizumab)Chugai PharmaceuticalNULLCompleted20 Years75 YearsBoth42Phase 3NULL
3NCT00144560
(ClinicalTrials.gov)
February 20052/9/2005Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)An Open-Label, Clinical Pharmacology Study to Investigate Drug-Drug Interaction in Patients With RARheumatoid ArthritisDrug: MRA(Tocilizumab)Chugai PharmaceuticalNULLCompleted20 Years75 YearsBoth31N/ANULL
4NCT00144573
(ClinicalTrials.gov)
January 20052/9/2005Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal ImpairmentAn Open-Label, Clinical Pharmacology Study to Evaluate the Safety and PK of MRA in Patients With RA With Renal ImpairmentRheumatoid ArthritisDrug: MRA(Tocilizumab)Chugai PharmaceuticalNULLCompleted20 Years75 YearsBoth14N/ANULL
5NCT00144547
(ClinicalTrials.gov)
April 20042/9/2005Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JPAn Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Participated in Study MRA012JPRheumatoid ArthritisDrug: MRA(Tocilizumab)Chugai PharmaceuticalNULLCompleted20 YearsN/ABoth241Phase 3NULL
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT00144521
(ClinicalTrials.gov)
February 20042/9/2005Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)A Double-Blind, Phase III Study to Evaluate the Efficacy and Safety of MRA in Patients With RARheumatoid ArthritisDrug: MRA(Tocilizumab);Drug: MRA placebo;Drug: MTX;Drug: MTX placeboChugai PharmaceuticalNULLCompleted20 Years75 YearsBoth127Phase 3NULL
7NCT00144651
(ClinicalTrials.gov)
August 20012/9/2005Study of MRA in Patients With Rheumatoid Arthritis (RA)An Open-label, Extension, Phase II Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With RA Who Were Participated in Study MRA009JPRheumatoid ArthritisDrug: MRA(Tocilizumab)Chugai PharmaceuticalNULLCompleted20 YearsN/ABoth135Phase 2NULL

107. 若年性特発性関節炎 [臨床試験数:151,薬物数:75(DrugBank:13),標的遺伝子数:16,標的パスウェイ数:90
Searched query = "Systemic juvenile idiopathic arthritis", "Systemic-onset juvenile idiopathic arthritis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
3 / 151 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00144664
(ClinicalTrials.gov)
November 20042/9/2005Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)An Open-Label, Phase III Study to Evaluate the Efficacy, Safety and PK of MRA in Patients With pJIASystemic Juvenile Idiopathic ArthritisDrug: MRA(Tocilizumab)Chugai PharmaceuticalNULLCompleted2 Years19 YearsBoth19Phase 3NULL
2NCT00144612
(ClinicalTrials.gov)
July 20042/9/2005Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)An Open-label, Extension, Phase III Study to Evaluate the Long-term Safety and Efficacy of MRA in Patients With sJIA Who Participated in Studies MRA011JP or MRA316JPSystemic Juvenile Idiopathic ArthritisDrug: MRA(Tocilizumab)Chugai PharmaceuticalNULLCompleted2 Years19 YearsBoth60Phase 3NULL
3NCT00144599
(ClinicalTrials.gov)
May 20042/9/2005Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)A Double-Blind, Phase III Study to Evaluate the Efficacy, Safety and PK of MRA in Patients With sJIASystemic Juvenile Idiopathic ArthritisDrug: MRA(Tocilizumab);Drug: placeboChugai PharmaceuticalNULLCompleted2 Years19 YearsBoth56Phase 3NULL